Galecto (GLTO) Stock Chart & Stock Price History → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free GLTO Stock Alerts $0.70 -0.01 (-1.40%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Galecto Stock Price Performance5 Day Performance+1.43%1 Month Performance-0.46%3 Month Performance+16.41%6 Month Performance+13.63%Year-To-Date Performance-1.38%1 Year Performance-65.19% Receive GLTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Galecto and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> GLTO Stock Chart for Wednesday, May, 8, 2024 GLTO Chart by TradingView Galecto Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$0.71$0.71$0.74$0.70118,395 shs$19.25 million05/06/2024$0.70$0.71+1.43%$0.73$0.70103,630 shs$19.25 million05/03/2024$0.72$0.70-2.36%$0.74$0.7024,864 shs$18.98 million05/02/2024$0.68$0.72+5.38%$0.73$0.68280,815 shs$19.44 million05/01/2024$0.69$0.68-1.25%$0.69$0.6647,208 shs$18.45 million04/30/2024$0.70$0.69-1.84%$0.72$0.66144,773 shs$18.68 million Get the Latest News and Ratings for GLTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galecto and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$0.70$0.70-0.41%$0.72$0.6796,651 shs$19.03 million04/26/2024$0.67$0.70+4.17%$0.71$0.66119,427 shs$18.84 million04/25/2024$0.67$0.67-0.55%$0.70$0.6526,332 shs$18.09 million04/24/2024$0.70$0.67-4.22%$0.71$0.6575,622 shs$18.19 million04/23/2024$0.68$0.70+2.88%$0.70$0.68106,964 shs$18.99 million04/22/2024$0.68$0.68-0.07%$0.72$0.6861,412 shs$18.46 million04/19/2024$0.72$0.68-5.35%$0.72$0.6876,564 shs$18.48 million04/18/2024$0.67$0.72+6.76%$0.72$0.65107,127 shs$19.52 million04/17/2024$0.68$0.67-0.59%$0.69$0.6560,222 shs$18.29 million04/16/2024$0.69$0.68-1.29%$0.68$0.6423,625 shs$18.39 million04/15/2024$0.68$0.69+0.93%$0.69$0.64111,894 shs$18.63 million04/12/2024$0.70$0.68-2.73%$0.72$0.68233,119 shs$18.46 million04/11/2024$0.68$0.70+2.96%$0.74$0.6697,192 shs$18.98 million04/10/2024$0.71$0.68-4.82%$0.71$0.65173,672 shs$18.44 million04/09/2024$0.71$0.71+0.14%$0.72$0.6866,609 shs$19.37 million04/08/2024$0.76$0.71-6.13%$0.79$0.60396,556 shs$19.34 million04/05/2024$0.73$0.76+4.10%$0.79$0.71317,606 shs$20.60 million04/04/2024$0.75$0.73-2.03%$0.77$0.7378,616 shs$19.79 million04/03/2024$0.77$0.75-2.60%$0.78$0.73124,797 shs$20.20 million04/02/2024$0.75$0.77+2.68%$0.78$0.7490,017 shs$20.74 million04/01/2024$0.78$0.75-4.49%$0.80$0.74162,690 shs$20.20 million03/29/2024$0.78$0.78$0.82$0.77129,262 shs$21.15 million03/28/2024$0.78$0.78$0.82$0.77128,972 shs$21.15 million03/27/2024$0.74$0.78+5.08%$0.84$0.74764,951 shs$21.15 million03/26/2024$0.74$0.74+0.08%$0.77$0.7438,896 shs$20.12 million03/25/2024$0.78$0.74-5.38%$0.78$0.74126,643 shs$20.11 million03/22/2024$0.77$0.78+2.34%$0.79$0.7465,767 shs$21.25 million03/21/2024$0.79$0.77-2.92%$0.79$0.7567,998 shs$20.77 million03/20/2024$0.76$0.79+3.82%$0.80$0.7750,312 shs$21.39 million03/19/2024$0.77$0.76-1.61%$0.82$0.76160,617 shs$20.60 million03/18/2024$0.82$0.77-5.56%$0.82$0.7762,440 shs$20.94 million03/15/2024$0.76$0.82+7.18%$0.82$0.7592,908 shs$22.17 million03/14/2024$0.75$0.76+1.60%$0.78$0.73259,654 shs$20.69 million03/13/2024$0.79$0.75-4.78%$0.83$0.75199,610 shs$20.37 millionThe Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>>03/12/2024$0.79$0.79-0.13%$0.82$0.74327,613 shs$21.38 million03/11/2024$0.87$0.79-9.23%$0.88$0.76257,778 shs$21.41 million03/08/2024$0.85$0.87+2.49%$0.94$0.84377,370 shs$23.59 million03/07/2024$0.89$0.85-4.66%$0.90$0.77359,328 shs$23.02 million03/06/2024$0.81$0.89+9.95%$0.91$0.78380,103 shs$24.14 million03/05/2024$0.87$0.81-6.89%$0.88$0.79419,999 shs$21.96 million03/04/2024$0.82$0.87+6.07%$0.92$0.80888,646 shs$23.58 million03/01/2024$0.72$0.82+13.86%$0.85$0.681.28 million shs$22.23 million02/29/2024$0.69$0.72+3.78%$0.78$0.68502,087 shs$19.53 million02/28/2024$0.68$0.69+2.04%$0.71$0.66149,567 shs$18.81 million02/27/2024$0.67$0.68+2.27%$0.70$0.66200,704 shs$18.44 million02/26/2024$0.66$0.67+0.21%$0.68$0.6369,241 shs$18.03 million02/23/2024$0.66$0.66+0.85%$0.68$0.6462,128 shs$17.99 million02/22/2024$0.69$0.66-4.65%$0.70$0.65126,963 shs$17.84 million02/21/2024$0.68$0.69+0.92%$0.70$0.65234,076 shs$18.71 million02/20/2024$0.70$0.68-2.48%$0.71$0.67157,805 shs$18.54 million02/19/2024$0.70$0.70$0.71$0.66218,100 shs$19.01 million02/16/2024$0.68$0.70+2.60%$0.71$0.66218,127 shs$18.92 million02/15/2024$0.69$0.68-1.93%$0.72$0.68158,448 shs$18.45 million02/14/2024$0.62$0.69+12.29%$0.71$0.64387,247 shs$18.81 million02/13/2024$0.65$0.62-4.51%$0.69$0.60184,336 shs$16.75 million02/12/2024$0.62$0.65+4.34%$0.69$0.62282,502 shs$17.54 million02/09/2024$0.61$0.63+2.90%$0.63$0.61148,337 shs$17.02 million02/08/2024$0.62$0.61-0.81%$0.65$0.60183,880 shs$16.54 million02/07/2024$0.60$0.62+2.76%$0.63$0.5991,530 shs$16.67 million Related Companies: Aptorum Group Stock Chart Indaptus Therapeutics Stock Chart NeuroSense Therapeutics Stock Chart KALA BIO Stock Chart BioVie Stock Chart Vincerx Pharma Stock Chart Avalo Therapeutics Stock Chart Sol-Gel Technologies Stock Chart Talphera Stock Chart Orgenesis Stock Chart Receive GLTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galecto and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLTO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galecto, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.